Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T McGuire

Showing results (241-250 of 288) with videos related to

Pageof 29
Sort By:
Cell Reports|May 5, 2021
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodiesEmilie Seydoux, Yu-Hsin Wan, Junli Feng, et al.
Elife|November 8, 2018
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 coreAndrew J Borst, Connor E Weidle, Matthew D Gray, et al.
Cell Reports. Medicine|May 23, 2024
Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirusKristina R Edwards, Karina Schmidt, Leah J Homad, et al.
Plos Pathogens|May 3, 2014
Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A virusesYuval Avnir, Aimee S Tallarico, Quan Zhu, et al.
Nature Communications|July 17, 2023
Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphomaXiao Chen, Yinglu Li, Fang Zhu, et al.
NPJ Vaccines|August 5, 2025
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelopeAndrew Wilcox-King, Yu-Hsin Wan, Samuel C Scharffenberger, et al.
Nature Communications|February 25, 2016
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic miceAndrew T McGuire, Matthew D Gray, Pia Dosenovic, et al.
Cell Reports. Medicine|February 18, 2026
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic developmentCrystal B Chhan, Kevin Lang, Amelia R Davis, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alexandra Tortorici, Young-Jun Park, et al.
Nature Structural & Molecular Biology|May 13, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alejandra Tortorici, Young-Jun Park, et al.
Pageof 29

Showing results (241-250 of 288) with videos related to

Sort By:
Pageof 29
Cell Reports|May 5, 2021
Development of a VRC01-class germline targeting immunogen derived from anti-idiotypic antibodiesEmilie Seydoux, Yu-Hsin Wan, Junli Feng, et al.
Elife|November 8, 2018
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 coreAndrew J Borst, Connor E Weidle, Matthew D Gray, et al.
Cell Reports. Medicine|May 23, 2024
Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirusKristina R Edwards, Karina Schmidt, Leah J Homad, et al.
Plos Pathogens|May 3, 2014
Molecular signatures of hemagglutinin stem-directed heterosubtypic human neutralizing antibodies against influenza A virusesYuval Avnir, Aimee S Tallarico, Quan Zhu, et al.
Nature Communications|July 17, 2023
Context-defined cancer co-dependency mapping identifies a functional interplay between PRC2 and MLL-MEN1 complex in lymphomaXiao Chen, Yinglu Li, Fang Zhu, et al.
NPJ Vaccines|August 5, 2025
Priming VRC01-precursor B cells with non-envelope immunogens disfavors boosting with HIV-1 envelopeAndrew Wilcox-King, Yu-Hsin Wan, Samuel C Scharffenberger, et al.
Nature Communications|February 25, 2016
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic miceAndrew T McGuire, Matthew D Gray, Pia Dosenovic, et al.
Cell Reports. Medicine|February 18, 2026
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic developmentCrystal B Chhan, Kevin Lang, Amelia R Davis, et al.
Biorxiv : the Preprint Server for Biology|January 5, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alexandra Tortorici, Young-Jun Park, et al.
Nature Structural & Molecular Biology|May 13, 2021
Structural basis for broad coronavirus neutralizationMaximilian M Sauer, M Alejandra Tortorici, Young-Jun Park, et al.
Pageof 29